Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review
This comprehensive review aimed to evaluate the relationship between SARS-CoV-2 infection (the cause of coronavirus disease 2019, or COVID-19) and the metabolic and endocrine characteristics frequently found in women with polycystic ovary syndrome (PCOS). In the general population, COVID-19 is more...
Gespeichert in:
| Veröffentlicht in: | Reviews in endocrine & metabolic disorders 2022-04, Vol.23 (2), p.251-264 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 264 |
|---|---|
| container_issue | 2 |
| container_start_page | 251 |
| container_title | Reviews in endocrine & metabolic disorders |
| container_volume | 23 |
| creator | de Medeiros, Sebastião Freitas Yamamoto, Márcia Marly Winck de Medeiros, Matheus Antônio Souto Yamamoto, Ana Karine Lin Winck Barbosa, Bruna Barcelo |
| description | This comprehensive review aimed to evaluate the relationship between SARS-CoV-2 infection (the cause of coronavirus disease 2019, or COVID-19) and the metabolic and endocrine characteristics frequently found in women with polycystic ovary syndrome (PCOS). In the general population, COVID-19 is more severe in subjects with dyslipidemia, obesity, diabetes mellitus, and arterial hypertension. Because these conditions are comorbidities commonly associated with PCOS, it was hypothesized that women with PCOS would be at higher risk for acquiring COVID-19 and developing more severe clinical presentations. This hypothesis was confirmed in several epidemiological studies. The present review shows that women with PCOS are at 28%-50% higher risk of being infected with the SARS-CoV-2 virus at all ages and that, in these women, COVID-19 is associated with increased rates of hospitalization, morbidity, and mortality. We summarize the mechanisms of the higher risk of COVID-19 infection in women with PCOS, particularly in those with carbohydrate and lipid abnormal metabolism, hyperandrogenism, and central obesity. |
| doi_str_mv | 10.1007/s11154-022-09715-y |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2640562393</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A703953112</galeid><sourcerecordid>A703953112</sourcerecordid><originalsourceid>FETCH-LOGICAL-c188y-14d141e0c78ce0e82d15134cf3f17148a300904625d25926fc40c50e576e6f413</originalsourceid><addsrcrecordid>eNptjs1Lw0AQxYMoWKv_gKcFz1tn9itZb6V-FQoVUa8hbCa6tc3W3bSS_96Agh7kHd7w-M3My7JzhAkC5JcJEbXiIAQHm6Pm_UE2Qp1LLgyYw2GWheUWtT7OTlJaAQg0Vo-yx4ew7l2fOu9Y2FexZ6lv6xg2xKq2ZtGn98SaENls-TK_5miZbxtynQ_tFZsyFzbbSG_UJr8nFmnv6fM0O2qqdaKzHx9nz7c3T7N7vljezWfTBXdYFD1HVaNCApcXjoAKUaNGqVwjG8xRFZUEsKCM0LXQVpjGKXAaSOeGTKNQjrOL77vbGD52lLpyFXaxHV6WwijQRkgrf6nXak3lUD50sXIbn1w5zUFaLRHFQE3-oQbVtPEutNT4If-z8AWRnmvy</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2640562393</pqid></control><display><type>article</type><title>Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review</title><source>Springer Nature - Complete Springer Journals</source><creator>de Medeiros, Sebastião Freitas ; Yamamoto, Márcia Marly Winck ; de Medeiros, Matheus Antônio Souto ; Yamamoto, Ana Karine Lin Winck ; Barbosa, Bruna Barcelo</creator><creatorcontrib>de Medeiros, Sebastião Freitas ; Yamamoto, Márcia Marly Winck ; de Medeiros, Matheus Antônio Souto ; Yamamoto, Ana Karine Lin Winck ; Barbosa, Bruna Barcelo</creatorcontrib><description>This comprehensive review aimed to evaluate the relationship between SARS-CoV-2 infection (the cause of coronavirus disease 2019, or COVID-19) and the metabolic and endocrine characteristics frequently found in women with polycystic ovary syndrome (PCOS). In the general population, COVID-19 is more severe in subjects with dyslipidemia, obesity, diabetes mellitus, and arterial hypertension. Because these conditions are comorbidities commonly associated with PCOS, it was hypothesized that women with PCOS would be at higher risk for acquiring COVID-19 and developing more severe clinical presentations. This hypothesis was confirmed in several epidemiological studies. The present review shows that women with PCOS are at 28%-50% higher risk of being infected with the SARS-CoV-2 virus at all ages and that, in these women, COVID-19 is associated with increased rates of hospitalization, morbidity, and mortality. We summarize the mechanisms of the higher risk of COVID-19 infection in women with PCOS, particularly in those with carbohydrate and lipid abnormal metabolism, hyperandrogenism, and central obesity.</description><identifier>ISSN: 1389-9155</identifier><identifier>EISSN: 1573-2606</identifier><identifier>DOI: 10.1007/s11154-022-09715-y</identifier><language>eng</language><publisher>New York: Springer</publisher><subject>Carbohydrate metabolism ; Comorbidity ; Coronaviruses ; COVID-19 ; Diabetes mellitus ; Dyslipidemia ; Epidemiology ; Hypertension ; Infection ; Infections ; Lipid metabolism ; Metabolic disorders ; Morbidity ; Obesity ; Ovaries ; Physiological aspects ; Polycystic ovary syndrome ; Reviews ; Severe acute respiratory syndrome coronavirus 2 ; Stein-Leventhal syndrome</subject><ispartof>Reviews in endocrine & metabolic disorders, 2022-04, Vol.23 (2), p.251-264</ispartof><rights>COPYRIGHT 2022 Springer</rights><rights>The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c188y-14d141e0c78ce0e82d15134cf3f17148a300904625d25926fc40c50e576e6f413</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>de Medeiros, Sebastião Freitas</creatorcontrib><creatorcontrib>Yamamoto, Márcia Marly Winck</creatorcontrib><creatorcontrib>de Medeiros, Matheus Antônio Souto</creatorcontrib><creatorcontrib>Yamamoto, Ana Karine Lin Winck</creatorcontrib><creatorcontrib>Barbosa, Bruna Barcelo</creatorcontrib><title>Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review</title><title>Reviews in endocrine & metabolic disorders</title><description>This comprehensive review aimed to evaluate the relationship between SARS-CoV-2 infection (the cause of coronavirus disease 2019, or COVID-19) and the metabolic and endocrine characteristics frequently found in women with polycystic ovary syndrome (PCOS). In the general population, COVID-19 is more severe in subjects with dyslipidemia, obesity, diabetes mellitus, and arterial hypertension. Because these conditions are comorbidities commonly associated with PCOS, it was hypothesized that women with PCOS would be at higher risk for acquiring COVID-19 and developing more severe clinical presentations. This hypothesis was confirmed in several epidemiological studies. The present review shows that women with PCOS are at 28%-50% higher risk of being infected with the SARS-CoV-2 virus at all ages and that, in these women, COVID-19 is associated with increased rates of hospitalization, morbidity, and mortality. We summarize the mechanisms of the higher risk of COVID-19 infection in women with PCOS, particularly in those with carbohydrate and lipid abnormal metabolism, hyperandrogenism, and central obesity.</description><subject>Carbohydrate metabolism</subject><subject>Comorbidity</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Diabetes mellitus</subject><subject>Dyslipidemia</subject><subject>Epidemiology</subject><subject>Hypertension</subject><subject>Infection</subject><subject>Infections</subject><subject>Lipid metabolism</subject><subject>Metabolic disorders</subject><subject>Morbidity</subject><subject>Obesity</subject><subject>Ovaries</subject><subject>Physiological aspects</subject><subject>Polycystic ovary syndrome</subject><subject>Reviews</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Stein-Leventhal syndrome</subject><issn>1389-9155</issn><issn>1573-2606</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNptjs1Lw0AQxYMoWKv_gKcFz1tn9itZb6V-FQoVUa8hbCa6tc3W3bSS_96Agh7kHd7w-M3My7JzhAkC5JcJEbXiIAQHm6Pm_UE2Qp1LLgyYw2GWheUWtT7OTlJaAQg0Vo-yx4ew7l2fOu9Y2FexZ6lv6xg2xKq2ZtGn98SaENls-TK_5miZbxtynQ_tFZsyFzbbSG_UJr8nFmnv6fM0O2qqdaKzHx9nz7c3T7N7vljezWfTBXdYFD1HVaNCApcXjoAKUaNGqVwjG8xRFZUEsKCM0LXQVpjGKXAaSOeGTKNQjrOL77vbGD52lLpyFXaxHV6WwijQRkgrf6nXak3lUD50sXIbn1w5zUFaLRHFQE3-oQbVtPEutNT4If-z8AWRnmvy</recordid><startdate>20220401</startdate><enddate>20220401</enddate><creator>de Medeiros, Sebastião Freitas</creator><creator>Yamamoto, Márcia Marly Winck</creator><creator>de Medeiros, Matheus Antônio Souto</creator><creator>Yamamoto, Ana Karine Lin Winck</creator><creator>Barbosa, Bruna Barcelo</creator><general>Springer</general><general>Springer Nature B.V</general><scope>3V.</scope><scope>7QP</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>20220401</creationdate><title>Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review</title><author>de Medeiros, Sebastião Freitas ; Yamamoto, Márcia Marly Winck ; de Medeiros, Matheus Antônio Souto ; Yamamoto, Ana Karine Lin Winck ; Barbosa, Bruna Barcelo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c188y-14d141e0c78ce0e82d15134cf3f17148a300904625d25926fc40c50e576e6f413</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Carbohydrate metabolism</topic><topic>Comorbidity</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Diabetes mellitus</topic><topic>Dyslipidemia</topic><topic>Epidemiology</topic><topic>Hypertension</topic><topic>Infection</topic><topic>Infections</topic><topic>Lipid metabolism</topic><topic>Metabolic disorders</topic><topic>Morbidity</topic><topic>Obesity</topic><topic>Ovaries</topic><topic>Physiological aspects</topic><topic>Polycystic ovary syndrome</topic><topic>Reviews</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Stein-Leventhal syndrome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Medeiros, Sebastião Freitas</creatorcontrib><creatorcontrib>Yamamoto, Márcia Marly Winck</creatorcontrib><creatorcontrib>de Medeiros, Matheus Antônio Souto</creatorcontrib><creatorcontrib>Yamamoto, Ana Karine Lin Winck</creatorcontrib><creatorcontrib>Barbosa, Bruna Barcelo</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>Reviews in endocrine & metabolic disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Medeiros, Sebastião Freitas</au><au>Yamamoto, Márcia Marly Winck</au><au>de Medeiros, Matheus Antônio Souto</au><au>Yamamoto, Ana Karine Lin Winck</au><au>Barbosa, Bruna Barcelo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review</atitle><jtitle>Reviews in endocrine & metabolic disorders</jtitle><date>2022-04-01</date><risdate>2022</risdate><volume>23</volume><issue>2</issue><spage>251</spage><epage>264</epage><pages>251-264</pages><issn>1389-9155</issn><eissn>1573-2606</eissn><abstract>This comprehensive review aimed to evaluate the relationship between SARS-CoV-2 infection (the cause of coronavirus disease 2019, or COVID-19) and the metabolic and endocrine characteristics frequently found in women with polycystic ovary syndrome (PCOS). In the general population, COVID-19 is more severe in subjects with dyslipidemia, obesity, diabetes mellitus, and arterial hypertension. Because these conditions are comorbidities commonly associated with PCOS, it was hypothesized that women with PCOS would be at higher risk for acquiring COVID-19 and developing more severe clinical presentations. This hypothesis was confirmed in several epidemiological studies. The present review shows that women with PCOS are at 28%-50% higher risk of being infected with the SARS-CoV-2 virus at all ages and that, in these women, COVID-19 is associated with increased rates of hospitalization, morbidity, and mortality. We summarize the mechanisms of the higher risk of COVID-19 infection in women with PCOS, particularly in those with carbohydrate and lipid abnormal metabolism, hyperandrogenism, and central obesity.</abstract><cop>New York</cop><pub>Springer</pub><doi>10.1007/s11154-022-09715-y</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1389-9155 |
| ispartof | Reviews in endocrine & metabolic disorders, 2022-04, Vol.23 (2), p.251-264 |
| issn | 1389-9155 1573-2606 |
| language | eng |
| recordid | cdi_proquest_journals_2640562393 |
| source | Springer Nature - Complete Springer Journals |
| subjects | Carbohydrate metabolism Comorbidity Coronaviruses COVID-19 Diabetes mellitus Dyslipidemia Epidemiology Hypertension Infection Infections Lipid metabolism Metabolic disorders Morbidity Obesity Ovaries Physiological aspects Polycystic ovary syndrome Reviews Severe acute respiratory syndrome coronavirus 2 Stein-Leventhal syndrome |
| title | Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T00%3A22%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Polycystic%20ovary%20syndrome%20and%20risks%20for%20COVID-19%20infection:%20A%20comprehensive%20review&rft.jtitle=Reviews%20in%20endocrine%20&%20metabolic%20disorders&rft.au=de%20Medeiros,%20Sebasti%C3%A3o%20Freitas&rft.date=2022-04-01&rft.volume=23&rft.issue=2&rft.spage=251&rft.epage=264&rft.pages=251-264&rft.issn=1389-9155&rft.eissn=1573-2606&rft_id=info:doi/10.1007/s11154-022-09715-y&rft_dat=%3Cgale_proqu%3EA703953112%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2640562393&rft_id=info:pmid/&rft_galeid=A703953112&rfr_iscdi=true |